Elon Musk is suing the company he helped found for $134 billion. He also happens to own its largest competitor. That uncomfortable fact sits at the center of the trial that opened in San Francisco this week, where Musk is asking a court to remove Sam Altman, unwind OpenAI’s corporate restructuring, and block its planned IPO — actions that would directly benefit Musk’s xAI venture as it races to catch the market leader it sued.
The case is being framed in court as a dispute over charitable trust law and the integrity of OpenAI’s nonprofit-to-commercial pivot. Strip away the doctrinal vocabulary and a different question emerges: can a tech billionaire weaponize charity law to kneecap a competitor at exactly the moment that competitor is trying to access public capital markets? That is what is actually on trial, according to MIT Technology Review’s coverage of the trial.
The Engineering of a Nonprofit Pivot
OpenAI’s corporate architecture is the kind of structure engineers would call a kludge. A nonprofit parent governs a capped-profit subsidiary, which in turn signed a multi-decade commercial partnership with Microsoft. The design was meant to reconcile two incompatible goals: pursue artificial general intelligence as a charitable mission while raising the tens of billions of dollars in compute that frontier AI requires.
That structure proved unstable. In October 2025, OpenAI completed a recapitalization that converted the for-profit subsidiary into a public benefit corporation, with the nonprofit retaining oversight and an equity stake. The restructuring cleared the way for an eventual IPO after sign-off from state regulators with jurisdiction over charitable assets in California and Delaware.
Musk’s $38 Million Question
Musk donated $38 million when OpenAI was founded in 2015 and served on its board until 2018. He left after a failed attempt to merge OpenAI with Tesla. The trial centers on whether his early financial support gives him standing to police what OpenAI does with its assets a decade later.
Most legal scholars say it does not. Under American charitable trust law, the enforcement of donor intent typically falls to state attorneys general, not to the donors themselves. The doctrine exists for a reason: courts would otherwise be flooded with second-guessing from anyone who once wrote a check.
The Competitor in the Plaintiff’s Chair
The financial stakes help explain why a peripheral donor is pursuing a case most experts think he should lose. OpenAI is now valued at over $850 billion and is targeting a public offering by year-end. Musk’s xAI, combined with SpaceX, carries a valuation of roughly $1.25 trillion. The two companies are competing head-to-head for enterprise customers, compute capacity, and AI talent.
The timing of Musk’s legal escalation tracks his own commercial calendar with uncomfortable precision. xAI closed a $6 billion Series C in late 2024, then raised another round at a $50 billion valuation in mid-2025 — the same months its founder was filing amended complaints and pushing for expedited discovery against OpenAI. Grok 3 launched in February 2025; Grok 4 followed before year-end. Each xAI fundraise and product announcement landed against a backdrop of legal filings designed to cloud OpenAI’s recapitalization. When Musk’s team won an accelerated trial date, OpenAI’s IPO planning slipped by months. xAI used that window to court the same sovereign wealth funds and infrastructure partners OpenAI was pitching.
The parallel campaign is hard to miss. Musk’s xAI venture has separately sued Apple and OpenAI on antitrust grounds, alleging the App Store privileges ChatGPT over Grok. He has used his social platform to amplify both cases to an audience of hundreds of millions. Every delay imposed on OpenAI is a quarter that xAI gets to close the gap.
OpenAI’s response has been blunt. The company has publicly dismissed the lawsuit as an attempt to harm a competitor and has published a timeline of internal communications it argues contradicts Musk’s account, including emails in which Musk himself acknowledged the need for a for-profit structure to raise capital. Musk’s legal team is seeking as much as $134 billion in damages — roughly 3,500 times his original donation.
Why Charitable Conversions Are Hard
The OpenAI dispute is a high-profile instance of a recurring problem in nonprofit law: what happens when a charity outgrows its original purpose, or when its leaders decide a different structure better serves the mission. Hospital systems, insurance mutuals, universities, and research institutes have all wrestled with versions of this question. State attorneys general review such deals, ensure charitable assets are not stripped, and impose conditions. They do not typically reverse conversions based on the objections of past donors.
What makes OpenAI different is scale and speed. The company went from research lab to one of the most valuable private companies in history in roughly seven years. The original nonprofit charter, drafted in an era when AGI seemed distant, must now govern a commercial enterprise whose products are used by hundreds of millions of people. The seams show — and Musk has spent two years yanking on them.
What Happens Next Week
The next phase of the trial is where the competitive damage gets done, regardless of how it ends. OpenAI executives, including Altman and Brockman, are scheduled to testify in coming days, exposing internal deliberations about safety governance, Microsoft’s role, and the timeline of the for-profit conversion. Every hour those executives spend in a witness chair is an hour they are not running the company or pitching IPO investors. Microsoft, which holds a 27% stake in the revamped partnership, will be watching for any testimony that complicates its own disclosures.
The judge is expected to rule on standing before the jury delivers its advisory verdict. If Musk is found to lack standing — the outcome most charitable trust scholars predict — the case ends without reaching the merits and OpenAI’s restructuring stands. If standing survives, the IPO timeline almost certainly slips into next year, and xAI gets the runway it has been buying with litigation.
That is the outcome readers should track. Not the abstract precedent for nonprofit governance, but the specific question of whether a competitor can use the courthouse to slow a rival’s access to public markets. The trial began as scheduled on April 27. By the time it ends, the answer will already be priced in.
Photo by Yan Krukau on Pexels
